RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Ensign Peak Advisors, Inc's Holding History (CIK: 0001454984)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 29,264 Value ($000) $120 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 409,936 Value ($000) $2,000 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 410,286 Value ($000) $2,076 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 410,286 Value ($000) $2,170 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 410,286 Value ($000) $2,774 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 408,986 Value ($000) $2,695 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 408,986 Value ($000) $3,067 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 398,936 Value ($000) $3,977 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 387,515 Value ($000) $3,821 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 214,970 Value ($000) $1,645 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 169,220 Value ($000) $1,264 Avg Close $7.00 Range $4.54 - $10.45
Q3 2022
Shares 15,470 Value ($000) $165 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 15,470 Value ($000) $126 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 15,470 Value ($000) $111 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 15,470 Value ($000) $265 Avg Close $18.82 Range $15.25 - $23.86